Narrativa’s article on Generative AI in Clinical Research published in AMWA

Exciting news! Our latest article, “Generative AI in Clinical Research: Regulatory Submissions, Clinical Data Management, and Beyond,” has been published in the American Medical Writers Association journal!

The American Writers Association Journal is an incredibly selective publication. Out of thousands of submissions yearly it only publishes the most cutting-edge and innovative pieces, making Ehab Naim, Javier Garcia, and Matthew Rectors’ article a remarkable achievement.

Not only does it show great promise, but it emphasizes and recognizes the importance of Generative AI in the medical field. The publication of this article in the AMWA reflects the relevance of companies like Narrativa and how they can lead the future of medicine.

The article

Artificial intelligence and its subsets such as generative AI have been making headlines recently. As a result, of their potential to accelerate the growth and expansion of various industries such as healthcare, the technology has been popularized. However, although the benefits of these technologies have been recognized, their application in healthcare revolves around diagnosing diseases, finding lead molecules, optimizing hospital operations, as well as other related aspects.

This implies, that there are areas where the potential of these technologies is yet to materialize. For instance, these technologies could produce a significant impact across multiple domains such as; clinical research and its related branches, clinical data management, clinical documentation, and other related fields.

When artificial intelligence and its related systems are employed in these sectors, they yield unparalleled outcomes regarding efficiency, consistency, and replicability. This, in turn, supports professionals involved in clinical research, such as medical writers, statistical programmers, and other stakeholders. AI considerably improves the speed at which the initial drafts of various outputs are produced, reduces the risk of errors that could lead to submission rejection, and optimizes the overall clinical research workflow. Despite the potential of AI in this area, few companies are able to produce the technology mentioned previously. Although some businesses have started to work on such programs, they still require work and research.

➡️ Read the full article:

https://amwajournal.org/index.php/amwa/article/view/304

About AMWA (American Medical Writers Association)

The American Medical Writers Association is a highly prestigious association, which aims to support and encourage excellence in medical communication. Since its foundation in 1940, it has become the leading association for medical and healthcare publications. Its promotion of medical writing has created a platform and community that is internationally recognized and has contributed to significant advances in the medical field. Therefore, medical writers and editors worldwide, aim to be published in this internationally acclaimed journal.

About the authors

Ehab Naim

Ehab is an experienced Medical Writer and Researcher with 5+ years of experience in the field of Medical Communications in the EMEA region and North America.

His experience involves working on projects for companies such as Pfizer, Abbott, Janssen, Merck, AstraZeneca, GSK, AbbVie, Sanofi, Eli Lilly, and many others of the top multinational pharmaceutical companies and CROs. He also collaborates with professors and researchers from North America, Europe, and other regions.

Javier García

As Chief Scientist at Narrativa, Javier leads innovation in Generative AI models. With over 15 years of experience, he excels in data analysis and artificial intelligence in the Life Sciences field.
Javier has directed the architecture and development of numerous impactful projects, enhancing product value in both startups and large corporations globally. His early career focused on computational methods and AI in the financial sector, providing a solid foundation for his current leadership role.

Matthew Rector

Matt is a PMP-certified content, digital media, and data analytics expert. He leads cross-functional initiatives on behalf of businesses and brands and has worked with organizations such as the United Nations, NBC, Live Nation, the PGA Tour, and Wright Entertainment Group.

About Narrativa

Narrativa® is the leading generative AI automation company focused on revolutionizing the Life Sciences field. Its proprietary and secure medical writing automation platform, equipped with built-in AI agents, quickly and accurately creates smart documentation such as CSRs (clinical study reports), patient narratives, TLFs (tables, listings, and figures), and redacted/anonymized files that empower pharmaceutical sponsors, biotechnology companies, and CROs (clinical research organizations). From database to delivery, Narrativa not only speeds up the clinical trial process and reduces errors, but authors complete documentation for medical writer review and submission to regulatory bodies—all without the need for teams to piece together parts of documents themselves. Accelerate the potential with Narrativa®.

For additional information, visit www.narrativa.com and follow on LinkedIn, Facebook, Instagram, and X.